Antiinflamatory agents less dangerous for gastrointestinal tract

Current Pharmaceutical Design

Volumn 7, Issue 10, 2001, Pages 951-976

  Rodriguez Tellez M ^a   Arguelles F ^a   Herrerias J M Jr ^a   Ledro, D ^a   Esteban, J ^a   Herrerias J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTICOAGULANT AGENT; CORTICOSTEROID DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MECLOFENAMIC ACID; MEFENAMIC ACID; MESALAZINE; NAPROXEN; NITRIC OXIDE DONOR; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE INHIBITOR; PRODRUG; PROSTAGLANDIN; SALICYLAMIDE; SALICYLIC ACID; SULINDAC; TOLMETIN; TRIFLUSAL; UNINDEXED DRUG;

AGE; ALCOHOL CONSUMPTION; ANAMNESIS; ANIMAL CELL; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DIGESTIVE SYSTEM PERFORATION; DRUG DESIGN; DRUG MECHANISM; DRUG SAFETY; DUODENUM ULCER; GASTROINTESTINAL TOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; RISK FACTOR; SMOKING; STEROID THERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ARACHIDONIC ACID; BICARBONATES; CELL DIVISION; DIGESTIVE SYSTEM; GASTRIC ACID; GASTRIC MUCOSA; HUMANS; MICROCIRCULATION; MUCUS; NEUTROPHILS; NITRIC OXIDE; OXIDATION-REDUCTION;

EID: 0034940141     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612013397663     Document Type: Article

References (172)